down arrow

CureVac NV

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0015436031
USD
5.12
0.01 (0.2%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Harmony Biosciences Holdings, Inc.
IDEAYA Biosciences, Inc.
Vericel Corp.
Ironwood Pharmaceuticals, Inc.
CureVac NV
PTC Therapeutics, Inc.
Xenon Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc.
Biohaven Ltd.
Neumora Therapeutics, Inc.
Why is CureVac NV ?
1
Poor Management Efficiency with a low ROE of 5.85%
  • The company has been able to generate a Return on Equity (avg) of 5.85% signifying low profitability per unit of shareholders funds
2
The company has declared negative results in Mar'2025 after 5 consecutive positive quarters
  • NET SALES(HY) At USD 16.37 MM has Grown at -56.57%
  • PRE-TAX PROFIT(Q) At USD -54.36 MM has Fallen at -201.91%
  • NET PROFIT(Q) At USD -54.82 MM has Fallen at -220.66%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is CureVac NV for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
CureVac NV
79.65%
0.23
66.32%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
73.53%
EBIT Growth (5y)
30.25%
EBIT to Interest (avg)
-4.41
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.31
Tax Ratio
13.37%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.14%
ROCE (avg)
21.88%
ROE (avg)
5.85%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
5
Industry P/E
Price to Book Value
1.42
EV to EBIT
2.08
EV to EBITDA
1.90
EV to Capital Employed
2.28
EV to Sales
0.91
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
109.38%
ROE (Latest)
29.24%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 169.9 MM

NET PROFIT(HY)

At USD -88.31 MM has Grown at 48.49%

ROCE(HY)

Highest at 34.46%

NET SALES(9M)

Higher at USD 558.95 MM

-14What is not working for the Company
NET SALES(HY)

At USD 16.37 MM has Grown at -56.57%

PRE-TAX PROFIT(Q)

At USD -54.36 MM has Fallen at -201.91%

NET PROFIT(Q)

At USD -54.82 MM has Fallen at -220.66%

INTEREST(HY)

At USD 0.56 MM has Grown at 50.76%

RAW MATERIAL COST(Y)

Grown by 99.15% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 6.37 times

Here's what is working for CureVac NV
Operating Cash Flow
Highest at USD 169.9 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Here's what is not working for CureVac NV
Net Sales
At USD 16.37 MM has Grown at -56.57%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (USD MM)

Pre-Tax Profit
At USD -54.36 MM has Fallen at -201.91%
over average net sales of the previous four periods of USD 53.35 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -54.82 MM has Fallen at -220.66%
over average net sales of the previous four periods of USD 45.43 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest
At USD 0.56 MM has Grown at 50.76%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Inventory Turnover Ratio
Lowest at 6.37 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost
Grown by 99.15% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."